Dashboard
Manage Tickers

BDTX


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-black-diamond-therapeutic-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Blac...
09/18/2024 11:03:41

HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and maintains $11...

reported-saturday-black-diamond-therapeutics-presents-real-world-data-on-nsclc-patients-with-non-classical-egfr-mutations-at-esmo-2024
Reported Saturday, Black Diamond Therapeut...
09/16/2024 08:40:22

Treatment data were analyzed from 3,276 cases of patients with newly diagnosed EGFR mutant NSCLC from Guardant Health Analys...

wedbush-reiterates-outperform-on-black-diamond-therapeutic-maintains-16-price-target
Wedbush Reiterates Outperform on Black Dia...
09/10/2024 12:50:16

Wedbush analyst Robert Driscoll reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform and maintains $16 price...

hc-wainwright--co-reiterates-buy-on-black-diamond-therapeutic-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Blac...
09/04/2024 11:28:15

HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and maintains $11...

looking-into-black-diamond-therapeutics-recent-short-interest
Looking Into Black Diamond Therapeutic's R...
08/22/2024 13:15:16

wedbush-reiterates-outperform-on-black-diamond-therapeutic-maintains-16-price-target
Wedbush Reiterates Outperform on Black Dia...
08/07/2024 14:37:48

Wedbush analyst Robert Driscoll reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform and maintains $16 price...

black-diamond-therapeutics-cash-cash-equivalents-and-investments-of-123m-as-of-june-30-2024-expected-to-be-sufficient-to-fund-operations-into-q4-of-2025
Black Diamond Therapeutics' Cash, Cash Equ...
08/06/2024 11:45:38

black-diamond-therapeutic-q2-2024-gaap-eps-036-misses-035-estimate
Black Diamond Therapeutic Q2 2024 GAAP EPS...
08/06/2024 11:44:50

raymond-james-initiates-coverage-on-black-diamond-therapeutic-with-outperform-rating-announces-price-target-of-20
Raymond James Initiates Coverage On Black ...
07/31/2024 09:42:17

Raymond James analyst Laura Prendergast initiates coverage on Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform rati...

piper-sandler-maintains-overweight-on-black-diamond-therapeutic-maintains-12-price-target
Piper Sandler Maintains Overweight on Blac...
07/03/2024 16:28:18

Piper Sandler analyst Joseph Catanzaro maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Overweight and maintains $12...

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
06/11/2024 16:31:11

hc-wainwright--co-reiterates-buy-on-black-diamond-therapeutic-maintains-11-price-target
HC Wainwright & Co. Reiterates Buy on Blac...
06/07/2024 11:17:50

HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and maintains $11...

reported-saturday-black-diamond-therapeutics-showcased-bdtx-1535-clinical-data-in-patients-with-recurrent-glioblastoma-at-2024-asco-annual-meeting
Reported Saturday, Black Diamond Therapeut...
06/03/2024 07:47:08

Results from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profil...

hc-wainwright--co-maintains-buy-on-black-diamond-therapeutic-lowers-price-target-to-11
HC Wainwright & Co. Maintains Buy on Black...
05/16/2024 11:36:42

HC Wainwright & Co. analyst Robert Burns maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and lowers the pri...

black-diamond-therapeutics-expects-cash--equivalents-of-1152m-as-of-march-end-to-be-sufficient-to-fund-operations-into-q3-of-2025
Black Diamond Therapeutics Expects Cash & ...
05/09/2024 12:12:51

black-diamond-therapeutic-q1-2024-gaap-eps-035-beats-044-estimate
Black Diamond Therapeutic Q1 2024 GAAP EPS...
05/09/2024 12:11:44

Black Diamond Therapeutic (NASDAQ:BDTX) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimat...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/23/2024 20:31:12

wedbush-maintains-outperform-on-black-diamond-therapeutic-raises-price-target-to-16
Wedbush Maintains Outperform on Black Diam...
04/08/2024 15:18:17

Wedbush analyst Robert Driscoll maintains Black Diamond Therapeutic (NASDAQ:BDTX) with a Outperform and raises the price tar...

black-diamond-therapeutics-presented novel-real-world-evidence-of-the-evolving-egfr-mutation-landscape-in-nsclc-and-the-opportunity-for-bdtx-1535-in-an-oral-presentation-at-the-2024-aacr-annual-meeting
Black Diamond Therapeutics Presented Novel...
04/08/2024 06:15:24

Real-world data demonstrate non-classical mutations are present in 20-30% of all patients with EGFRm NSCLC Emerging data sho...

hc-wainwright--co-reiterates-buy-on-black-diamond-therapeutic-raises-price-target-to-12
HC Wainwright & Co. Reiterates Buy on Blac...
03/18/2024 10:46:13

HC Wainwright & Co. analyst Robert Burns reiterates Black Diamond Therapeutic (NASDAQ:BDTX) with a Buy and raises the pr...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION